We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
Brigatinib @ is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)
The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.
Trade Partners
Franchise
Download PDF
+91-9953494942